Reffind Ltd.

Reffind Ltd.


If you’ve been tracking the progress of ‘blockchain’ — the tech that makes Bitcoin and the like possible — you might know that this cutting-edge FinTech is improving the lives of financiers and online e-commerce customers.

Software as a Service (SaaS) solutions provider, Reffind Ltd. (ASX:RFN) doesn’t want to miss out on the next big thing.

The company is actively pursuing major opportunities for its core product offerings in the ASEAN and Asia-Pacific markets in the cloud-based enterprise SaaS and BaaS sectors and recently announced a strategic investment and licensing deal with Loyyal as another key step in its accelerated growth strategy.

Loyyal is a universal rewards platform built with blockchain and smart contract technology.

RFN wants to maximize these opportunities by accelerating the adoption of its existing products and by pursuing complementary value accretive SaaS and BaaS opportunities.

It is one of only a handful of emergent blockchain/DLT companies and it is looking to grow rapidly –being on the hunt for strong early-stage companies to make snappy acquisitions.

RFN plans to identify and acquire more entities and pursue blockchain commercialisation via one of three avenues: Architecture, Platforms and Customer-focused products. It plans to actively evolve the current SaaS free-for-all, into a higher calibre solution, capable of serving a wider range of customers and enterprises.

The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.

RFN has secured what it needs to lead the business through its next stage of organic and investment based growth, leveraging existing and Blockchain software. This is a significant milestone in its ability to expand organically and rapidly grow in key international markets.

Having raised more than A$6 million over the past year, and with a new CEO at the helm, RFN could be on its way to lifting its circa A$13 million market valuation in the near term.

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free